Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older
- You must weigh at least 40 kg (about 88 pounds)
- You must have valid health insurance
- You must have been diagnosed with lupus according to specific 2019 international guidelines (confirm with trial site)
- You must have active lupus that is currently affecting your joints and/or kidneys, with a disease activity score above a certain level (confirm with trial site)
Who may not be able to join:
- You cannot join if you are a minor, pregnant, or currently breastfeeding
- You cannot join if you are under any form of legal protection, guardianship, or court supervision
- You cannot join if you are currently being held in a facility or are under enforced hospitalization
- You cannot join if you are currently receiving dialysis (a kidney filtering treatment) or plasma exchange (a blood cleaning treatment)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chantal DUMESTRE-PERARD, Professor, Grenoble Alpes University Hospital
Phone: 0476765015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quantification of anti-C1s autoantibodies purified from the serum of lupus patients with active disease, targeting N-terminal, C-terminal domains and C1s protease mutants.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.